A vesicle-based platform for high-efficiency, high-viability CRISPR/Cas9 knockout in primary human myeloid cells
Silvia Fiori, Maira Russo, Alice Randon, Alessio Nicola Ferraro, Tiziana Julia Nadjeschda Schmidt, Elena Pinca, Rana Kamel Mohamed Ali Elnady, Ivan Castello-Serrano, Paola Capasso, Abeer Mahfoud, Giorgia Moschetti, Edoardo Scarpa, Loris Rizzello, Niklas Arndt Schmacke, Veit Hornung, , Manuel Albanese
This paper develops a vesicle-based CRISPR/Cas9 platform for efficient gene knockout in primary human myeloid cells, preserving viability and enabling downstream functional studies.
bioRxiv · Aug 3, 2026 · PreprintImmunology